ClinicalTrials.gg
Active, not recruitingNCT07864324Updated Oct 7, 2026

High-Intensity Interval Training and Mental Health in Psychiatric Inpatients: A Pilot Study

An interventional study of High-Intensity Interval Training (1 × 4) in Anxiety, Depression and Mental Health, sponsored by University Hospital of North Norway. Active, not recruiting at 1 site in Norway. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by University Hospital of North Norway · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 8 months after the study started (first participant enrolled Jan 2025, registered Oct 2026).
Updated Oct 7, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The goal of this pilot clinical trial is to investigate the feasibility of conducting a high-intensity interval training intervention among adult inpatients in a psychiatric care setting and to explore changes in mental health symptoms.

Participants are randomized to either high-intensity interval training or treatment as usual. Participants in the intervention group complete a 1 × 4-minute high-intensity interval training program on a treadmill three times per week for two weeks. Participants in the control group receive treatment as usual.

Anxiety and depression symptoms and general mental health are assessed before and after the intervention period. Feasibility is assessed by recruitment rate and participant dropout.

02

Conditions studied

  • Anxiety
  • Depression
  • Mental Health
  • Psychiatric Inpatients
03

In context

Anxiety Disorders

5,063 studies on the registry are indexed under Anxiety Disorders; 1,408 are open to participants now.

This study's planned enrollment of 10 is below the median of 80 across 4,339 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

University Hospital of North Norway is the lead sponsor of 151 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-60 years
  • Currently admitted to the Medication-Free Treatment Unit, Mental Health and Substance Abuse Clinic
  • At least one previous psychiatric inpatient admission

Exclusion criteria

Exclusion Criteria:

- Somatic conditions incompatible with high-intensity exercise, including cardiovascular disease, musculoskeletal conditions, or pulmonary disease

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    High-Intensity Interval Training

    Participants receive high-intensity interval training (1 × 4) on a treadmill three times per week for two weeks, for a total of six sessions. Each session consists of a 10-minute warm-up, followed by one 4-minute high-intensity interval at 85-95% of maximum heart rate, and a 5-minute cool-down.

    Behavioral: High-Intensity Interval Training (1 × 4)

  • Active comparator
    Treatment as Usual

    Participants assigned to this group receive treatment as usual (TAU) and continue with the usual activities and procedures provided during their psychiatric inpatient stay. No additional exercise intervention is provided as part of the study.

    Behavioral: High-Intensity Interval Training (1 × 4)

Interventions

  • BehavioralHigh-Intensity Interval Training (1 × 4)

    Participants complete high-intensity interval training on a treadmill three times per week for two weeks, for a total of six sessions. Each session consists of a 10-minute warm-up, followed by one 4-minute high-intensity interval at 85-95% of maximum heart rate, and a 5-minute cool-down, for a total duration of 19 minutes. Heart rate is monitored continuously using a chest strap and heart rate monitor. The training sessions are supervised by an exercise physiologist.

06

What researchers measure

Primary outcomes

  1. Change in Anxiety and Depression Symptom

    Anxiety and depression symptoms are assessed using the Hospital Anxiety and Depression Scale (HADS). HADS consists of 14 items divided into two 7-item subscales: HADS-A for anxiety and HADS-D for depression.

    Time frame: Baseline and immediately after the two-week intervention period.

Secondary outcomes

  1. Feasibility: Recruitment Rate

    Feasibility of conducting a high-intensity interval training study among psychiatric inpatients will be assessed by the recruitment rate. The number of participants recruited to the study will be recorded in relation to the planned sample size of 10 participants.

    Time frame: Throughout the study recruitment period

  2. Feasibility: Participant Dropout

    Feasibility of conducting a high-intensity interval training study among psychiatric inpatients will be assessed by participant dropout. The number and proportion of enrolled participants who discontinue the study before completing the study procedures will be recorded.

    Time frame: From enrollment through completion of the two-week study period

  3. Change in General Mental Health

    General mental health is assessed using the 12-item General Health Questionnaire (GHQ-12), assessing stress and subjective well-being

    Time frame: Baseline and immediately after the two-week intervention period.

07

Study locations

1 site
  • University Hospital of North Norway
    Tromsø, Norway
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be publicly shared due to the small sample size and the potentially sensitive nature of the data collected from psychiatric inpatients, which may increase the risk of participant identification.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Dec 2026, 23 months after the start.

Of 2,720 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 23 months is above that.

Counting every sponsor, half of 2,789 studies reached it within 12 months; a quarter within 5 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 2, 2026
First posted
Oct 7, 2026
StartActual
Jan 15, 2025
Primary completionEst.
Dec 15, 2026
CompletionEst.
Mar 1, 2027
Last update
Oct 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 7, 2026
Show all 1 update
  1. Oct 7, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07864324
Responsible party
Sponsor
First posted
Oct 7, 2026
Start date
Jan 15, 2025
Primary completion
Dec 15, 2026 (estimated)
Completion
Mar 1, 2027 (estimated)
Last update
Oct 7, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion